Navigation Links
Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo

Boston, MA (PRWEB) April 02, 2013

Cambridge Semantics will again be a featured presenter at the annual Bio-IT World Conference & Expo. During this month’s event, Cambridge Semantics Vice President of Marketing and Technology, Lee Feigenbaum will speak on a new conference track, “Data Visualization and Exploration” which highlights novel visualization approaches that address important challenges in genomic data, networks, microscopy, imaging and the support of discovery, clinical and translational research. During his session, Mr. Feigenbaum will address Unified Information Access and its role in data exploration and visualization. To learn more visit or visit the Cambridge Semantics booth #129 at the event.

Featured presentation:

  •     Date and time: Wednesday, April 10th at 12:00 p.m. EST
  •     Title: Whence the Data? The Importance of Feeding the Right Data to Your Visualizations
  •     Session description: Visualizations are only as good as the data that drives them.
Frequently, the right data comes from many and diverse sources. This discussion will present the case for Unified Information Access, a paradigm that lets you easily combine structured and unstructured data from inside and outside your organization in support of ever-evolving data exploration and visualization. Examples will include practical applications for competitive intelligence, safety, and assay data management.

In addition, Cambridge Semantics executives will be onsite at booth #129 demonstrating the company’s Competitive Intelligence and Drug Safety & Pharmacovigilance solutions. At the 2012 Bio-IT World Conference Cambridge Semantics’ Competitive Intelligence Solution was named “Best of Show” for its unique approach to helping pharma companies handle their diverse and ever-changing information needs. The company’s Drug Safety & Pharmacovigilance solution helps pharma reduce operational cost and improve risk management by automating and streamlining the process of discovering, managing, and analyzing adverse drug reactions.

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit or follow us on Twitter @CamSemantics.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
2. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
3. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
4. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
5. Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers
6. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
7. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
8. Clinverse CEO to Speak at MAGI East 2013
9. Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
10. iLuv Introducing NFC & Qi-Certified Technology to Bluetooth Speaker Lineup at 2013 CES
11. VBI’s Dr. Szczepan Baran is an Invited Speaker at the Swiss Laboratory Animal (SGV) National Meeting
Post Your Comments:
(Date:11/26/2015)... , England , November 26, 2015 /PRNewswire/ ... Medical, an innovative medical device company specializing in imaging technologies, ... from the European Commission as part of the Horizon 2020 ... company to carry out a large-scale clinical trial in breast ...      (Logo: , --> ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT ... provide a corporate overview. th Annual Oppenheimer Healthcare ... ET/10:00 a.m. PT . Jim Mazzola , vice president ... --> th Annual Oppenheimer Healthcare Conference in ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris , qui ... Paris , qui s,est tenu du ... leader de l,innovation biométrique, a inventé le premier scanner ... sur la même surface de balayage. Jusqu,ici, deux scanners ... les empreintes digitales. Désormais, un seul scanner est en ...
(Date:11/12/2015)... 2015  A golden retriever that stayed healthy despite ... has provided a new lead for treating this muscle-wasting ... Institute of MIT and Harvard and the University of ... Cell, pinpoints a protective gene that ... effects. The Boston Children,s lab of Lou Kunkel ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):